Boston Scientific Corp (BSX)
91.50
+1.33
(+1.48%)
USD |
NYSE |
Nov 21, 16:00
91.50
0.00 (0.00%)
After-Hours: 20:00
Boston Scientific Enterprise Value: 143.48B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 143.48B |
| November 20, 2024 | 141.52B |
| November 19, 2024 | 141.76B |
| November 18, 2024 | 141.93B |
| November 15, 2024 | 136.84B |
| November 14, 2024 | 137.72B |
| November 13, 2024 | 139.46B |
| November 12, 2024 | 139.38B |
| November 11, 2024 | 139.03B |
| November 08, 2024 | 138.69B |
| November 07, 2024 | 136.67B |
| November 06, 2024 | 136.02B |
| November 05, 2024 | 134.70B |
| November 04, 2024 | 133.49B |
| November 01, 2024 | 131.87B |
| October 31, 2024 | 132.46B |
| October 30, 2024 | 132.41B |
| October 29, 2024 | 133.25B |
| October 28, 2024 | 133.52B |
| October 25, 2024 | 133.47B |
| October 24, 2024 | 134.02B |
| October 23, 2024 | 137.48B |
| October 22, 2024 | 138.30B |
| October 21, 2024 | 138.36B |
| October 18, 2024 | 138.39B |
| Date | Value |
|---|---|
| October 17, 2024 | 135.96B |
| October 16, 2024 | 136.82B |
| October 15, 2024 | 136.48B |
| October 14, 2024 | 137.63B |
| October 11, 2024 | 136.96B |
| October 10, 2024 | 135.64B |
| October 09, 2024 | 136.37B |
| October 08, 2024 | 135.11B |
| October 07, 2024 | 133.00B |
| October 04, 2024 | 133.19B |
| October 03, 2024 | 132.13B |
| October 02, 2024 | 133.12B |
| October 01, 2024 | 132.60B |
| September 30, 2024 | 132.10B |
| September 27, 2024 | 130.64B |
| September 26, 2024 | 130.24B |
| September 25, 2024 | 130.86B |
| September 24, 2024 | 130.87B |
| September 23, 2024 | 131.59B |
| September 20, 2024 | 131.47B |
| September 19, 2024 | 131.17B |
| September 18, 2024 | 129.49B |
| September 17, 2024 | 129.41B |
| September 16, 2024 | 130.87B |
| September 13, 2024 | 130.58B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
45.92B
Minimum
Mar 23 2020
143.48B
Maximum
Nov 21 2024
78.50B
Average
69.83B
Median
Sep 08 2022
Enterprise Value Benchmarks
| Baxter International Inc | 28.43B |
| Haemonetics Corp | 5.216B |
| ResMed Inc | 36.01B |
| Globus Medical Inc | 11.30B |
| Abbott Laboratories | 210.81B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 468.00M |
| Revenue (Quarterly) | 4.209B |
| Total Expenses (Quarterly) | 3.491B |
| EPS Diluted (Quarterly) | 0.32 |
| Gross Profit Margin (Quarterly) | 68.83% |
| Profit Margin (Quarterly) | 11.12% |
| Earnings Yield | 1.32% |
| Operating Earnings Yield | 2.08% |
| Normalized Earnings Yield | 1.582 |